title: [Electroconvulsive therapy for neurological disorders].
abstract: Electroconvulsive therapy (ECT) recovers the brain function through generalized convulsion induced by electrical stimulation of the brain. While the primary targets of ECT are psychiatric disorders such as depression, schizophrenia, and schizoaffective disorder, it has been well documented that ECT has therapeutic effects on muscular rigidity of Parkinson's disease and neuroleptics-induced malignant syndrome. Recently we demonstrated that ECT reduces intractable pain and allodynia associated with deafferentation pain disorders by recovering the function of the thalamic nucleus. ECT, if applied on appropriate clinical assessments, may contribute to the therapeutics of neuropsychiatric disorders.
authors: Department of Neuropsychiatry, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.
authors: Nagafumi
authors: N
authors: Doi
authors: Tatsuo
authors: T
authors: Sameshima
authors: Hiroshi
authors: H
authors: Suwa
authors: Hitoshi
authors: H
authors: Mera
authors: Takehiko
authors: T
authors: Nagao
authors: Masayuki
authors: M
authors: Yokochi
authors: Mitsuru
authors: M
authors: Nakamura
authors: Kunihiro
authors: K
authors: Isse
mesh_terms: D000368:Aged; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D009422:Nervous System Diseases / Q000628:therapy*; D010148:Intractable Pain / Q000628:therapy; D010300:Parkinson Disease / Q000628:therapy